1. What Is the Point of Care Immunoassay Market?
The Point of Care Immunoassay Market covers lateral flow rapid antigen tests and portable immunoassay readers providing antibody-antigen detection at the bedside, clinic, or home within 15 to 30 minutes. POC immunoassay encompasses influenza rapid antigen, COVID-19 rapid antigen, cardiac troponin POC, fertility hormone lateral flow, and quantitative POC reader platforms. Market dynamics reflect COVID-19 normalising rapid antigen home testing, cardiac POC troponin enabling 1-hour AMI rule-out in ED, and fever panel rapid antigen multi-disease differentiation.
2. Point of Care Immunoassay Market Size & Forecast
3. Emerging Technologies
- High-sensitivity cardiac troponin POC systems achieving sub-5-ng/L detection limits enabling 0-hour AMI rule-out are advancing as ED efficiency tools. Growing adoption at EDs is driven by faster AMI rule-out requiring fewer serial troponin draws.
- Multiplex fever panel rapid antigen tests simultaneously differentiating influenza, RSV, COVID, and strep A are advancing. Growing adoption at primary care is driven by same-visit differential diagnosis for febrile illness.
- Digital lateral flow test readers with smartphone connectivity enabling quantitative result from qualitative strip are advancing. Growing adoption is driven by result objectivity improvement and remote data capture requirements.
- POC immunoassay at retail pharmacy enabling consumer-initiated infection screening are advancing as access tools. Growing adoption is driven by primary care decongestion and consumer health monitoring requirements.
Such innovations are driving change across adjacent industries too. Discover more in our Immunoassay Market.
4. Key Market Opportunity
Revenue is concentrated in the Point of Care Immunoassay Market at the home and retail rapid antigen test sub-market, where COVID-19 consumer adoption creates a large recurring rapid antigen market. Cardiac troponin POC creates a premium ED revenue opportunity as high-sensitivity troponin achieves 1-hour AMI rule-out enabling ED throughput improvement. Fertility POC immunoassay creates a consumer revenue channel as home ovulation and pregnancy testing achieves consumer scale. Asia Pacific POC immunoassay creates geographic expansion as Chinese, Indian, and Southeast Asian primary care POC testing adoption grows.
5. Top Companies in the Point of Care Immunoassay Market
The following organisations hold leading positions in the Point of Care Immunoassay Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Abbott (BinaxNOW, Panbio, i-STAT Cardiac)
- Roche (Cardiac Reader, Elecsys)
- Quidel (Sofia 2)
- Siemens (Rapid Reader)
- OraSure Technologies
- bioMerieux (VIDAS rapid)
- LumiraDx
- Standard BioTools
- Thermo Fisher (Acugen)
- Becton Dickinson (rapid diagnostic)
6. Market Segmentation
The Point of Care Immunoassay Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Test Type | Rapid Antigen Lateral Flow Quantitative POC Reader ELFA Enzyme-Linked Multiplex LFA |
| By Application | Respiratory Antigen Cardiac Troponin Fertility Hormone Infectious Disease Screen Drug Screen |
| By Setting | Home Self-Test Primary Care ED Pharmacy |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Point of Care Immunoassay Market trajectory over the forecast period:
Abbott Panbio COVID-19 and BinaxNOW Achieve 500 Million Annual Rapid Antigen Test Sales.Abbott BinaxNOW and Panbio COVID-19 rapid antigen tests achieving 500 million combined annual unit sales in 2024 demonstrate rapid antigen immunoassay at consumer scale. Abbott BinaxNOW retail pharmacy distribution achieving 50 million consumer home test kit sales in 2024 demonstrates the mainstream consumer rapid antigen test market.
Roche Cardiac Reader High-Sensitivity Troponin Achieves 50 Percent Global POC Cardiac Market Share.Roche Cardiac Reader high-sensitivity troponin T quantitative POC system achieving 50 percent global POC cardiac immunoassay market share demonstrates troponin POC market concentration. High-sensitivity troponin POC achieving 0-hour and 1-hour AMI rule-out algorithm performance equivalent to central laboratory demonstrates POC immunoassay clinical equivalency for AMI diagnosis.
Quidel Sofia SARS-CoV-2 and Influenza POC Achieves 15-Minute Multiplex Rapid Antigen Standard.Quidel Sofia 2 flu and strep A plus SARS-CoV-2 multiplex fluorescent immunoassay achieving 15-minute simultaneous result in 2024 demonstrates multiplex POC rapid antigen at primary care clinic standard. Sofia achieving 30,000 US primary care clinic installations demonstrates the scale of fluorescent quantitative POC immunoassay reader adoption.
For related market intelligence, see the Point Of Care Molecular Diagnostics Market.
8. Segmental Analysis
By test type, the Rapid Antigen Lateral Flow segment dominated the Point of Care Immunoassay Market in 2025. Representing the largest unit volume as consumer COVID-19 and influenza rapid antigen testing drives 500-million-plus annual test volume. The Quantitative Cardiac Troponin POC Reader segment is the fastest-growing clinical category, advancing as high-sensitivity troponin enables AMI rule-out at POC.
By setting, the Home and Consumer Self-Test segment dominated in 2025 by unit volume.
By application, the Respiratory Antigen segment dominated the Point of Care Immunoassay Market in 2025, as influenza A/B, RSV, and COVID-19 rapid antigen tests represent the highest-volume point-of-care immunoassay application globally. Cardiac Troponin is the fastest-growing application category, driven by high-sensitivity troponin POC assays enabling rule-out acute myocardial infarction in emergency and chest pain unit settings.
9. Regional Analysis
Regional demand patterns across the Point of Care Immunoassay Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Point of Care Immunoassay Market in 2025, holding 46.7% of the global market. Primary care clinics, emergency departments, and physician office laboratories are deploying point-of-care immunoassay systems for rapid troponin, influenza, strep A, RSV, and fertility hormone testing to enable clinical decisions without laboratory delay. FDA CLIA waiver approvals for point-of-care immunoassay platforms and CMS reimbursement for physician office laboratory testing are encouraging physician practice adoption of decentralised immunoassay systems. High patient visit volumes, strong physician demand for rapid diagnostic results, and established POC testing reimbursement are generating regional demand.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 14.46% during the forecast period. Primary care facilities, community health centres, and point-of-care testing networks across China, India, Japan, and Southeast Asia are deploying immunoassay POC systems for rapid testing of infectious disease markers, hormones, and cardiac biomarkers outside hospital laboratories. Government primary care investment and expanding community health centre infrastructure are creating demand for affordable, portable immunoassay systems capable of rapid testing in diverse clinical settings. Rising demand for decentralised diagnostic services outside hospital laboratory settings and growing point-of-care testing awareness among regional clinicians are generating adoption.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Point of Care Immunoassay Market was valued at USD 3.83 Bn in 2025 and is projected to reach USD 10.79 Bn by 2034, growing at a CAGR of 12.2% over the 2026–2034 forecast period.
The Point of Care Immunoassay Market is projected to grow at a CAGR of 12.2% from 2026 to 2034.
North America accounted for the largest share of the Point of Care Immunoassay Market in 2025, holding 46.7% of the global market.
The leading companies in the Point of Care Immunoassay Market include Abbott (BinaxNOW, Panbio, i-STAT Cardiac), Roche (Cardiac Reader, Elecsys), Quidel (Sofia 2), Siemens (Rapid Reader), OraSure Technologies, bioMerieux (VIDAS rapid), LumiraDx, Standard BioTools, Thermo Fisher (Acugen), Becton Dickinson (rapid diagnostic).
Abbott panbio covid-19 and binaxnow achieve 500 million annual rapid antigen test sales.
By test type, the Rapid Antigen Lateral Flow segment dominated the Point of Care Immunoassay Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.